Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Carya Laciniosa Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Shellbark Hickory pollen allergies through skin testing and immunotherapy.
Name
Carya Laciniosa Pollen
Raw Name
CARYA LACINIOSA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
4
Variant Count
5
Last Verified
February 17, 2026
About Carya Laciniosa Pollen
Carya Laciniosa Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Shellbark Hickory pollen allergies through skin testing and immunotherapy.
Detailed information about Carya Laciniosa Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Carya Laciniosa Pollen.
The FDA has regulated allergenic extracts for decades, with many being approved based on their historical use and demonstrated efficacy in identifying and treating Type I hypersensitivity reactions (allergic reactions). Carya Laciniosa Pollen is specifically indicated for patients who exhibit symptoms of hay fever (allergic rhinitis) or asthma during the spring months when hickory trees release their airborne pollen. Your healthcare provider, typically an allergist or immunologist, may use this extract to determine if you are sensitized to this specific tree species and to formulate a treatment plan to reduce your allergic sensitivity over time.
The mechanism of action for Carya Laciniosa Pollen depends on whether it is being used for diagnosis or therapy. In diagnostic skin testing, the extract is introduced into the skin (percutaneously or intradermally). If the patient has pre-existing IgE antibodies specific to hickory pollen, these antibodies—which are bound to mast cells in the skin—will recognize the pollen proteins. This recognition triggers the release of histamine and other inflammatory mediators, resulting in a 'wheal and flare' reaction (a raised bump and surrounding redness). This reaction confirms that the patient's immune system is sensitized to the allergen.
In therapeutic applications, known as Allergen Immunotherapy (AIT) or 'allergy shots,' the extract is administered in gradually increasing doses. This process aims to induce 'immune tolerance.' At the molecular level, this involves several complex changes in the immune system. Initially, there is a decrease in the activity of Th2 cells (which promote allergy) and an increase in Th1 and regulatory T-cells (Tregs). These regulatory cells produce cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which suppress the allergic response. Furthermore, immunotherapy induces the production of 'blocking antibodies' (IgG4), which can intercept the allergen before it can bind to IgE on mast cells, effectively preventing the allergic cascade from starting.
Traditional pharmacokinetic studies (absorption, distribution, metabolism, and excretion) are not typically conducted for allergenic extracts like Carya Laciniosa Pollen because they are not systemic medications in the traditional sense. However, the following principles apply to their clinical use:
Carya Laciniosa Pollen extracts are FDA-approved for the following clinical indications:
Carya Laciniosa Pollen is available in several liquid formulations, which vary based on the intended use and the manufacturer's preparation:
> Important: Only your healthcare provider can determine if Carya Laciniosa Pollen is right for your specific condition. The selection of the appropriate concentration and administration schedule is a highly individualized process that must be managed by a specialist.
Dosage for Carya Laciniosa Pollen is not standardized across all patients; it must be individualized based on the patient's level of sensitivity, which is determined through skin testing and clinical history.
Carya Laciniosa Pollen is used in children, as allergies often manifest early in life. However, special care must be taken:
No specific dosage adjustments are required for patients with renal impairment, as the extract is not primarily cleared by the kidneys in a way that affects its immunological activity.
No dosage adjustments are needed for patients with liver disease.
Elderly patients may have a higher risk of cardiovascular complications if a systemic reaction occurs. Physicians may adjust the dose more cautiously and monitor heart rate and blood pressure more frequently during the build-up phase.
Carya Laciniosa Pollen extracts are for professional use only and should never be self-administered by the patient at home.
If a dose is missed during the build-up phase, the next dose may need to be reduced depending on how much time has passed. If more than one or two weeks have passed since the last injection, the allergist will typically repeat the previous dose or even drop back several levels to ensure safety. Do not attempt to 'double up' on doses to make up for a missed appointment.
An 'overdose' in the context of allergenic extracts usually refers to the administration of a dose that exceeds the patient's current tolerance level. Signs of an overdose (systemic reaction) include:
In the event of an overdose or systemic reaction, the immediate administration of epinephrine (adrenaline) is the primary treatment. Emergency medical services must be contacted immediately if symptoms occur outside the clinical setting.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or skip appointments without medical guidance, as this increases the risk of a severe reaction.
Most patients receiving Carya Laciniosa Pollen injections will experience local reactions at the site of administration. These are generally not dangerous but can be uncomfortable.
These reactions are more significant and may require a temporary adjustment in the dosing schedule.
Rarely, patients may experience systemic symptoms that do not reach the level of full anaphylaxis but still require medical attention.
> Warning: Stop taking Carya Laciniosa Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Carya Laciniosa Pollen, as it is a natural protein extract. However, the primary long-term consideration is the potential for the development of new sensitivities, though this is rare. The goal of long-term use (3-5 years) is actually the opposite: to produce a long-lasting reduction in symptoms that persists even after the injections are stopped.
Carya Laciniosa Pollen, like all allergenic extracts, carries a significant warning regarding the risk of anaphylaxis.
FDA Summary of Warning for Allergenic Extracts:
Report any unusual symptoms, especially those occurring several hours after your injection, to your healthcare provider immediately.
Carya Laciniosa Pollen is a potent biological substance that must be handled with extreme caution. It is intended only for use by physicians experienced in the diagnosis and treatment of allergic diseases. Patients should be in relatively good health at the time of their injection; if you are suffering from an acute infection, fever, or an exacerbation of your asthma, your injection should be postponed.
No FDA black box warnings for Carya Laciniosa Pollen specifically, but it falls under the general class warning for all allergenic extracts. The primary warning is for Anaphylaxis. Anaphylaxis is a sudden, systemic, and potentially fatal allergic reaction. Because the onset of anaphylaxis is unpredictable, the 30-minute post-injection waiting period is a mandatory safety requirement that cannot be waived. Patients should also be educated on how to use an epinephrine auto-injector if a delayed reaction occurs after they leave the clinic.
Generally, Carya Laciniosa Pollen does not affect the ability to drive. However, if a patient experiences a systemic reaction, dizziness, or is given antihistamines/epinephrine to treat a reaction, they should not drive or operate heavy machinery until the symptoms and the effects of the rescue medications have completely resolved.
There is no direct chemical interaction between alcohol and Carya Laciniosa Pollen. However, alcohol consumption can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of allergen absorption or mask the early signs of an allergic reaction. It is generally advised to avoid heavy alcohol use on the day of an injection.
Unlike many medications, there is no 'withdrawal syndrome' associated with stopping Carya Laciniosa Pollen. However, if treatment is stopped prematurely (before 3-5 years), the allergic symptoms are likely to return. If a patient chooses to stop, no tapering is required, but they should discuss alternative management strategies with their doctor.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Carya Laciniosa Pollen.
While there are few absolute contraindications regarding drug combinations, the following is the most critical:
There are no known direct food interactions with Carya Laciniosa Pollen. However, patients with 'Oral Allergy Syndrome' (OAS) may experience cross-reactivity. People allergic to hickory pollen (which is related to pecan trees) may sometimes experience itching in the mouth when eating pecans or walnuts. This is not a drug-food interaction in the metabolic sense but an immunological cross-reactivity.
There is limited data on herbal interactions. However, supplements that have immune-modulating effects (such as Echinacea or high-dose Astragalus) should be discussed with an allergist, as they could theoretically interfere with the goal of inducing immune tolerance.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any heart or blood pressure medications.
Carya Laciniosa Pollen must NEVER be used in the following circumstances:
In these cases, the doctor will perform a careful risk-benefit analysis:
Carya Laciniosa (Shellbark Hickory) is closely related to other members of the Carya genus, most notably Carya illinoinensis (Pecan). Patients allergic to hickory pollen are almost always allergic to pecan pollen. There is also some cross-reactivity with Walnut (Juglans) species. If you have had a severe reaction to any of these tree pollens in the past, your doctor will use extreme caution when testing or treating you with Carya Laciniosa Pollen.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Carya Laciniosa Pollen.
Carya Laciniosa Pollen is classified as Pregnancy Category C. This means there are no adequate and well-controlled studies in pregnant women.
It is not known whether the components of Carya Laciniosa Pollen are excreted in human milk. However, since the extract consists of natural proteins that are processed locally by the immune system, it is highly unlikely that significant amounts would reach the breast milk or affect a nursing infant. Immunotherapy is generally considered safe for breastfeeding mothers.
Renal impairment does not significantly alter the pharmacodynamics of allergenic extracts. No specific dose adjustments are listed in the FDA-approved labeling for patients with kidney disease. However, the patient's overall health status should be stable.
Hepatic impairment does not affect the processing of allergenic extracts. There are no specific requirements for dose adjustment in patients with liver disease.
> Important: Special populations require individualized medical assessment and a cautious approach to immunotherapy.
Carya Laciniosa Pollen acts as a biological modifier of the immune system. In a sensitized individual, the immune system incorrectly identifies hickory pollen proteins as a threat, producing IgE antibodies. When these proteins are reintroduced via immunotherapy, the goal is to reprogram this response.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | N/A (Processed by Immune Cells) |
| Half-life | N/A (Biological degradation) |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Proteolysis by macrophages/dendritic cells |
| Excretion | Not renally excreted as intact drug |
Carya Laciniosa Pollen is classified as a Non-Standardized Pollen Allergenic Extract. It belongs to the broader therapeutic category of Allergenics used for both in-vivo diagnosis and immunotherapy. It is related to other tree pollen extracts like Oak, Maple, and Birch, but it is immunologically distinct, though it shares high cross-reactivity with Pecan pollen.
Common questions about Carya Laciniosa Pollen
Carya Laciniosa Pollen extract is primarily used for the diagnosis and treatment of allergies to Shellbark Hickory tree pollen. In a diagnostic setting, it is applied to the skin to see if a patient develops a 'wheal and flare' reaction, confirming an allergy. Therapeutically, it is used in 'allergy shots' (immunotherapy) to desensitize the patient's immune system over time. This treatment is intended for those with seasonal allergic rhinitis or asthma that is triggered by hickory pollen. By receiving gradually increasing doses, the body learns to tolerate the pollen, leading to fewer symptoms during the spring season.
The most common side effects are local reactions at the site where the extract was injected or applied. These include redness, swelling, itching, and a small raised bump known as a wheal. These reactions typically appear within minutes and usually resolve within a few hours to a day. Some patients may also feel slightly tired or have a mild headache after their injection. While these local reactions are common and usually harmless, very large swellings should be reported to your doctor. It is important to remember that these side effects are a sign that your immune system is interacting with the allergen.
There is no direct chemical interaction between alcohol and Carya Laciniosa Pollen extracts, but caution is advised. Alcohol can cause blood vessels to dilate, which might theoretically speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic reaction. Furthermore, being under the influence of alcohol can make it harder for you to recognize the early, subtle symptoms of an allergic reaction. Most allergists recommend avoiding alcohol for several hours before and after your allergy shot. Always follow the specific safety guidelines provided by your immunology clinic.
Carya Laciniosa Pollen is generally not started as a new treatment during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the baby. However, if a woman is already on a stable maintenance dose of immunotherapy and is tolerating it well, many doctors will continue the treatment. The main concern is the drop in blood pressure or oxygen levels that could occur during a severe allergic reaction. Decisions regarding immunotherapy during pregnancy are made on a case-by-case basis. You must inform your allergist immediately if you become pregnant while receiving these injections.
Immunotherapy with Carya Laciniosa Pollen is a long-term commitment and does not provide immediate relief like an antihistamine. Most patients begin to feel a reduction in their allergy symptoms after 6 to 12 months of consistent treatment, once they have reached a higher dose level. The full benefits of the treatment are usually seen after the second or third year of therapy. A standard course of treatment typically lasts between 3 and 5 years to ensure the immune system remains desensitized. If you stop the treatment too early, your symptoms are more likely to return.
Yes, you can stop taking Carya Laciniosa Pollen injections suddenly without experiencing physical withdrawal symptoms. Unlike some medications that require tapering, allergenic extracts do not cause a chemical dependency. However, stopping the treatment before the recommended 3-to-5-year period will likely result in the return of your allergy symptoms over time. If you are having trouble with the injection schedule or side effects, talk to your allergist. They may be able to adjust your dose or the frequency of your visits rather than stopping the treatment entirely.
If you miss a dose of Carya Laciniosa Pollen, you should contact your allergist's office to reschedule as soon as possible. Do not attempt to take an extra dose later. The safety of immunotherapy depends on the consistent and gradual increase of the allergen. If too much time passes between doses, your sensitivity to the pollen may increase, making your next scheduled dose potentially dangerous. Your doctor will determine if your next dose needs to be reduced or if you need to repeat a previous level of the build-up phase to ensure your safety.
There is no clinical evidence to suggest that Carya Laciniosa Pollen extracts cause weight gain. The extract consists of a very small amount of natural proteins and a stabilizer like glycerin, neither of which has enough caloric content or metabolic effect to influence body weight. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking (like oral corticosteroids for asthma). Discuss any concerns about weight with your primary care physician.
Carya Laciniosa Pollen can be taken alongside most common medications, but there are some important exceptions. You must tell your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more severe or harder to treat. Antihistamines should be avoided before skin testing because they can hide the results, but they are often used during the treatment phase to help with local itching. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you use.
The concept of 'generic' drugs is slightly different for allergenic extracts. Carya Laciniosa Pollen is produced by several different biological laboratories (such as Greer, ALK, or Jubilant HollisterStier). While they all contain the same Shellbark Hickory pollen proteins, they are considered 'non-standardized' and may have slight variations in their preparation. Your allergist will usually stick with one manufacturer's product for your entire course of treatment to ensure consistency in dosing. These extracts are generally covered by insurance as specialty biological products rather than as standard generic or brand-name pills.